Stephens Starts Pacific Biosciences of California (PACB) at Equal Weight
Tweet
Share
E-mailGet Alerts PACB Hot Sheet
Price: $1.47 --0%
Rating Summary:
9 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 8 | New: 14
Rating Summary:
9 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 8 | New: 14
Join SI Premium – FREE
Stephens initiated coverage on Pacific Biosciences of California (NASDAQ: PACB) with an Equal Weight rating and a price target of $6.50.
For an analyst ratings summary and ratings history on Pacific Biosciences of California click here. For more ratings news on Pacific Biosciences of California click here.
Shares of Pacific Biosciences of California closed at $6.20 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Craig-Hallum Assumes DiaMedica Therapeutics Inc. (DMAC) at Buy
- JPMorgan Downgrades Pacific Biosciences of California (PACB) to Neutral
- CICC Starts Southern Copper (SCCO) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
